Sonnest, Inc. is pre-clinical healthcare company developing Electrastâ„¢, an ultrasound imaging drug that circulates through the body in the inactive state (dark on ultrasound) and is selectively activated (turned on) in the myocardium. With Electrastâ„¢ doctors will be able to evaluate perfusion of the heart quickly and cost-effectively at the point of care without exposure to ionizing radiation or toxic dies. The technology was developed by a talented team of cardiologists and chemical engineers at Drexel University with grant funding from the Coulter-Drexel Program and the inventors partnered with a team of successful serial healthcare entrepreneurs who have worked together for over 15 years across multiple companies to form Sonnest.
View Top Employees from Sonnest, Inc.Website | http://www.sonnest.com |
Employees | 10 (5 on RocketReach) |
Address | 323 West Camden Street Suite 600, Baltimore, Maryland 21201, US |
Industry | Medical Equipment Manufacturing |
Looking for a particular Sonnest, Inc. employee's phone or email?
Josh White is the CEO of Sonnest, Inc..
5 people are employed at Sonnest, Inc..
Sonnest, Inc. is based in Baltimore, Maryland.